Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo de réir Deborah Watson-Jones, Shelley Lees, Brian Greenwood, Daniel G Bausch, Peter G Smith, Chrissy H Roberts, Nathalie Imbault, Anton Camacho, W John Edmunds, Eric Delaporte, Melanie Saville, John Johnson, Ira M Longini, Hugo Kavunga-Membo, Rebecca F Grais, Steve Ahuka, Natalie Roberts, Edward M Choi, Tansy Edwards, Maarten Leyssen, Bart Spiessens, Kerstin Luhn, Macaya Douoguih, Richard Hatchett, Jean-Jacques Muyembe, W John Edmunds, Daniela Manno, Rebecca Grais, Susan Rattigan, Grace Mambula, Patient Mumbere Kighoma, Marie Burton, Gerald Voss

Faigh an téacs iomlán